Skip to main content

Table 1 Baseline characteristics

From: Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)

N

HC 215

UC 215

P-value

Age, year

61.3 (11.3)

59.9 (11.1)

0.212

Male,%

75.8%

73.5%

0.579

Smoking status

  • Never smoked

25.1%

30.2%

0.398

  • Previous smoker

43.7%

38.1%

  • Current smoker

31.1%

31.6%

Doctor visits in last six months

4.55 (4.18)

4.79 (4.24)

0.588

Number of times admitted to hospital in last six months

1.99 (0.95)

1.97 (0.95)

0.840